These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 26982013)

  • 1. Three-Dimensional Imaging Using Contrast-Enhanced and Three-Dimensional Ultrasound Techniques in the Ablative Zone Treated with a Multipolar Radiofrequency Ablation System for Hepatocellular Carcinoma.
    Tanaka T; Ikeda K; Sorin Y; Fukushima T; Kawamura Y; Kobayashi M; Kumada H
    Oncology; 2016; 90(5):255-60. PubMed ID: 26982013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D fusion is superior to 2D point-to-point contrast-enhanced US to evaluate the ablative margin after RFA for hepatocellular carcinoma.
    Long H; Zhou X; Zhang X; Ye J; Huang T; Cong L; Xie X; Huang G
    Eur Radiol; 2024 Feb; 34(2):1247-1257. PubMed ID: 37572191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intra-procedural fusion imaging combining contrast-enhanced ultrasound using a perflubutane-based contrast agent and auto sweep three-dimensional ultrasound for guiding radiofrequency ablation and evaluating its efficacy in patients with hepatocellular carcinoma.
    Sanga K; Numata K; Nihonmatsu H; Ogushi K; Fukuda H; Chuma M; Hashimoto H; Koizumi N; Maeda S
    Int J Hyperthermia; 2020; 37(1):202-211. PubMed ID: 32070164
    [No Abstract]   [Full Text] [Related]  

  • 4. [Application value of real-time three-dimensional contrast-enhanced ultrasound for morphological assessing of hepatocellular carcinoma before radiofrequency ablation treatment].
    Wang XC; Li SY; Fang Y; Zhou L; Xu LL; Wu Y
    Zhonghua Zhong Liu Za Zhi; 2018 Mar; 40(3):217-221. PubMed ID: 29575843
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of contrast-enhanced ultrasound in planning treatment protocols for hepatocellular carcinoma before radiofrequency ablation.
    Chen MH; Yang W; Yan K; Dai Y; Wu W; Fan ZH; Callstrom MR; Charboneau JW
    Clin Radiol; 2007 Aug; 62(8):752-60. PubMed ID: 17604763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound.
    Dong Y; Wang WP; Mao F; Ji ZB; Huang BJ
    J Gastroenterol Hepatol; 2016 Apr; 31(4):822-8. PubMed ID: 26480287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring during hepatic radiofrequency ablation (RFA): comparison of real-time ultrasound elastography (RTE) and contrast-enhanced ultrasound (CEUS): first clinical results of 25 patients.
    Wiggermann P; Brünn K; Rennert J; Loss M; Wobser H; Schreyer AG; Stroszczynski C; Jung EM
    Ultraschall Med; 2013 Dec; 34(6):590-4. PubMed ID: 24132649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The minimal ablative margin of radiofrequency ablation of hepatocellular carcinoma (> 2 and < 5 cm) needed to prevent local tumor progression: 3D quantitative assessment using CT image fusion.
    Kim YS; Lee WJ; Rhim H; Lim HK; Choi D; Lee JY
    AJR Am J Roentgenol; 2010 Sep; 195(3):758-65. PubMed ID: 20729457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contrast-enhanced sonography with abdominal virtual sonography in monitoring radiofrequency ablation of hepatocellular carcinoma.
    Kisaka Y; Hirooka M; Koizumi Y; Abe M; Matsuura B; Hiasa Y; Onji M
    J Clin Ultrasound; 2010; 38(3):138-44. PubMed ID: 20014137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fusion imaging with contrast-enhanced ultrasonography for evaluating the early therapeutic efficacy of radiofrequency ablation for small hypervascular hepatocellular carcinomas with iso-echoic or unclear margins on conventional ultrasonography.
    Nishigori S; Numata K; Irie K; Fukuda H; Chuma M; Maeda S
    J Med Ultrason (2001); 2018 Jul; 45(3):405-415. PubMed ID: 29362966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contrast-enhanced ultrasound-guided radiofrequency ablation in inconspicuous hepatocellular carcinoma on B-mode ultrasound.
    Kim EJ; Kim YS; Shin SK; Kwon OS; Choi DJ; Kim JH
    Turk J Gastroenterol; 2017 Nov; 28(6):446-452. PubMed ID: 29086712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fusion imaging techniques and contrast-enhanced ultrasound for thermal ablation of hepatocellular carcinoma - A prospective randomized controlled trial.
    Huang Q; Zeng Q; Long Y; Tan L; Zheng R; Xu E; Li K
    Int J Hyperthermia; 2019; 36(1):1207-1215. PubMed ID: 31813295
    [No Abstract]   [Full Text] [Related]  

  • 13. Immediate evaluation and guidance of liver cancer thermal ablation by three-dimensional ultrasound/contrast-enhanced ultrasound fusion imaging.
    Xu EJ; Lv SM; Li K; Long YL; Zeng QJ; Su ZZ; Zheng RQ
    Int J Hyperthermia; 2018 Sep; 34(6):870-876. PubMed ID: 28847188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrating contrast-enhanced sonography in the follow-up algorithm of hepatocellular carcinoma treated with radiofrequency ablation: single cancer center experience.
    Catalano O; Izzo F; Vallone P; Sandomenico F; Albino V; Nunziata A; Fusco R; Petrillo A
    Acta Radiol; 2015 Feb; 56(2):133-42. PubMed ID: 24523360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of three-dimensional Gd-EOB-DTPA-enhanced MR fusion imaging with CT fusion imaging in the assessment of treatment effect of radiofrequency ablation of hepatocellular carcinoma.
    Makino Y; Imai Y; Igura T; Hori M; Fukuda K; Sawai Y; Kogita S; Fujita N; Takehara T; Murakami T
    Abdom Imaging; 2015 Jan; 40(1):102-11. PubMed ID: 25052767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of contrast-enhanced ultrasound (CEUS) in evaluation of thermal ablation zone.
    Lekht I; Gulati M; Nayyar M; Katz MD; Ter-Oganesyan R; Marx M; Cen SY; Grant E
    Abdom Radiol (NY); 2016 Aug; 41(8):1511-21. PubMed ID: 26969495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamic Three-Dimensional Contrast-Enhanced Ultrasound to Predict Therapeutic Response of Radiofrequency Ablation in Hepatocellular Carcinoma: Preliminary Findings.
    Cao J; Dong Y; Mao F; Wang W
    Biomed Res Int; 2018; 2018():6469703. PubMed ID: 30225261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Sonazoid-enhanced three-dimensional ultrasonography in the evaluation of percutaneous radiofrequency ablation of hepatocellular carcinoma.
    Luo W; Numata K; Morimoto M; Oshima T; Ueda M; Okada M; Takebayashi S; Zhou X; Tanaka K
    Eur J Radiol; 2010 Jul; 75(1):91-7. PubMed ID: 19361941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-dimensional ultrasound fusion imaging in precise needle placement for thermal ablation of hepatocellular carcinoma.
    Liu J; Guo Y; Sun Y; Liu M; Zhang X; Zheng R; Cong L; Liu B; Xie X; Huang G
    Int J Hyperthermia; 2024; 41(1):2316097. PubMed ID: 38360570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.